Alkermes
ALKS
$23.85
Share price
0.38%
Change (1 day)
-18.29%
Change (1 year)
Categories
Alkermes (ALKS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.93 B
According to Alkermes's latest financial reports the company's total liabilities are $0.93 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Alkermes - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.93 B | 1.45% |
| 2022-12-31 | $0.92 B | 0.91% |
| 2021-12-31 | $0.91 B | 3.3% |
| 2020-12-31 | $0.88 B | 22.61% |
| 2019-12-31 | $0.71 B | 10.13% |
| 2018-12-31 | $0.65 B | 9.98% |
| 2017-12-31 | $0.59 B | 14.99% |
| 2016-12-31 | $0.51 B | -4.53% |
| 2015-12-31 | $0.54 B | 3.69% |
| 2014-12-31 | $0.52 B | |
| 2013-03-31 | $0.51 B | -10.91% |
| 2012-03-31 | $0.58 B | 862.05% |
| 2011-03-31 | $60.43 M | -41.32% |
| 2010-03-31 | $0.10 B | -21.74% |
| 2009-03-31 | $0.13 B | -62.51% |
| 2008-03-31 | $0.35 B | -3.88% |
| 2007-03-31 | $0.36 B | -17.75% |
| 2006-03-31 | $0.44 B | 32.62% |
| 2005-03-31 | $0.33 B | 72.47% |
| 2004-03-31 | $0.19 B | -25.56% |
| 2003-03-31 | $0.26 B | 4.01% |
| 2002-03-31 | $0.25 B | 3.21% |
| 2001-03-31 | $0.24 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 10,481.69% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | 5,598.22% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 14,598.19% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 6,071.47% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $65.67 B | 6,934.96% | 🇺🇸 USA |
 AstraZeneca AZN | $61.95 B | 6,536.37% | 🇬🇧 UK |
 Acorda Therapeutics
ACOR | $0.30 B | -67.07% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 3,687.00% | 🇮🇱 Israel |